CASI

CASI Pharmaceuticals
CASI

Delisted

CASI was delisted on the 25th of February, 2026.

Back to rankings

1 hedge funds and large institutions have $25 invested in CASI Pharmaceuticals in 2026 Q1 according to their latest regulatory filings, with 0 funds opening new positions, 1 increasing their positions, 0 reducing their positions, and 15 closing their positions.

Upgrade to unlock
New
Increased
Maintained
Reduced
Closed

less ownership

Funds ownership: →

less funds holding

Funds holding: →

less capital invested

Capital invested by funds: $ → $

less first-time investments, than exits

New positions opened: | Existing positions closed:

Holders
1
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
–
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
–
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$86

Top Sellers

1
-$839K
2
-$113K
3
-$36.6K
4
Two Sigma Investments
Two Sigma Investments
New York
-$20.2K
5
Bank of America
Bank of America
North Carolina
-$16.9K
Name Holding Trade Value Shares
Change 		Change in
Stake
Simplex Trading
1
Simplex Trading
Illinois
$25
VA
2
VR Adviser
New York
–
WP
3
Woodline Partners
California
–
Renaissance Technologies
4
Renaissance Technologies
New York
–
Two Sigma Investments
5
Two Sigma Investments
New York
–
Bank of America
6
Bank of America
North Carolina
–
Geode Capital Management
7
Geode Capital Management
Massachusetts
–
Citadel Advisors
8
Citadel Advisors
Florida
–
Royal Bank of Canada
9
Royal Bank of Canada
Ontario, Canada
–
UBS Group
10
UBS Group
Switzerland
–
Wells Fargo
11
Wells Fargo
California
–
Morgan Stanley
12
Morgan Stanley
New York
–
BNP Paribas Financial Markets
13
BNP Paribas Financial Markets
France
–
JP Morgan Chase
14
JP Morgan Chase
New York
–
CT
15
Colonial Trust
South Carolina
–
MCM
16
MAI Capital Management
Ohio
–